

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of cell killing (GO:0031342) | 6.13794676 |
| 2 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 6.13794676 |
| 3 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.74055689 |
| 4 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 5.05381360 |
| 5 | response to interleukin-15 (GO:0070672) | 4.94988496 |
| 6 | negative T cell selection (GO:0043383) | 4.92368585 |
| 7 | cellular response to interleukin-15 (GO:0071350) | 4.72966205 |
| 8 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.70877937 |
| 9 | negative thymic T cell selection (GO:0045060) | 4.67553234 |
| 10 | positive T cell selection (GO:0043368) | 4.49450190 |
| 11 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.37469084 |
| 12 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.36726697 |
| 13 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.36726697 |
| 14 | positive thymic T cell selection (GO:0045059) | 4.29395173 |
| 15 | regulation of gamma-delta T cell activation (GO:0046643) | 4.22630283 |
| 16 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.09070127 |
| 17 | T cell selection (GO:0045058) | 4.02747451 |
| 18 | mast cell activation (GO:0045576) | 3.99437409 |
| 19 | immunoglobulin mediated immune response (GO:0016064) | 3.93605903 |
| 20 | thymic T cell selection (GO:0045061) | 3.86773616 |
| 21 | B cell receptor signaling pathway (GO:0050853) | 3.84342988 |
| 22 | interferon-gamma production (GO:0032609) | 3.82309040 |
| 23 | regulation of isotype switching to IgG isotypes (GO:0048302) | 3.78672353 |
| 24 | mast cell activation involved in immune response (GO:0002279) | 3.68262572 |
| 25 | mast cell degranulation (GO:0043303) | 3.68262572 |
| 26 | ribosomal small subunit assembly (GO:0000028) | 3.64415741 |
| 27 | T cell receptor signaling pathway (GO:0050852) | 3.64190829 |
| 28 | T cell homeostasis (GO:0043029) | 3.64160329 |
| 29 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.59404797 |
| 30 | regulation of granulocyte differentiation (GO:0030852) | 3.52643340 |
| 31 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.48288287 |
| 32 | T cell costimulation (GO:0031295) | 3.46216439 |
| 33 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.43884070 |
| 34 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.43884070 |
| 35 | modulation by symbiont of host immune response (GO:0052553) | 3.43884070 |
| 36 | positive regulation by symbiont of host defense response (GO:0052509) | 3.43884070 |
| 37 | modulation by symbiont of host defense response (GO:0052031) | 3.43884070 |
| 38 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.43884070 |
| 39 | neutrophil activation involved in immune response (GO:0002283) | 3.43862320 |
| 40 | lymphocyte costimulation (GO:0031294) | 3.43751927 |
| 41 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.39511058 |
| 42 | B cell mediated immunity (GO:0019724) | 3.39321255 |
| 43 | response to muramyl dipeptide (GO:0032495) | 3.39000223 |
| 44 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.37291009 |
| 45 | regulation of B cell differentiation (GO:0045577) | 3.36353158 |
| 46 | V(D)J recombination (GO:0033151) | 3.29943626 |
| 47 | regulation of regulatory T cell differentiation (GO:0045589) | 3.27967713 |
| 48 | B cell homeostasis (GO:0001782) | 3.26817933 |
| 49 | detection of bacterium (GO:0016045) | 3.24128785 |
| 50 | T cell migration (GO:0072678) | 3.23133918 |
| 51 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.20165894 |
| 52 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.18358927 |
| 53 | cellular extravasation (GO:0045123) | 3.15048259 |
| 54 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 3.12708289 |
| 55 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.11583266 |
| 56 | positive regulation of B cell activation (GO:0050871) | 3.06820420 |
| 57 | viral transcription (GO:0019083) | 3.06402315 |
| 58 | detection of other organism (GO:0098543) | 3.04856232 |
| 59 | positive regulation of B cell differentiation (GO:0045579) | 3.04700238 |
| 60 | leukocyte aggregation (GO:0070486) | 3.03618839 |
| 61 | mucosal-associated lymphoid tissue development (GO:0048537) | 3.02217717 |
| 62 | Peyers patch development (GO:0048541) | 3.02217717 |
| 63 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.99350668 |
| 64 | type I interferon signaling pathway (GO:0060337) | 2.99052505 |
| 65 | cellular response to type I interferon (GO:0071357) | 2.99052505 |
| 66 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 2.98095121 |
| 67 | activated T cell proliferation (GO:0050798) | 2.98079372 |
| 68 | response to type I interferon (GO:0034340) | 2.97944102 |
| 69 | negative regulation of T cell mediated immunity (GO:0002710) | 2.96382001 |
| 70 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.95639669 |
| 71 | regulation of alpha-beta T cell activation (GO:0046634) | 2.93863306 |
| 72 | defense response to protozoan (GO:0042832) | 2.92414621 |
| 73 | lymphocyte homeostasis (GO:0002260) | 2.91949574 |
| 74 | germinal center formation (GO:0002467) | 2.91102346 |
| 75 | translational termination (GO:0006415) | 2.90590360 |
| 76 | T cell differentiation (GO:0030217) | 2.89363860 |
| 77 | positive regulation of granulocyte differentiation (GO:0030854) | 2.89322681 |
| 78 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 2.89222381 |
| 79 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.88668609 |
| 80 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.88526052 |
| 81 | alternative mRNA splicing, via spliceosome (GO:0000380) | 2.88494915 |
| 82 | positive regulation of alpha-beta T cell differentiation (GO:0046638) | 2.86442619 |
| 83 | response to protozoan (GO:0001562) | 2.85826720 |
| 84 | positive regulation of alpha-beta T cell activation (GO:0046635) | 2.85707027 |
| 85 | positive regulation of interleukin-4 production (GO:0032753) | 2.85190371 |
| 86 | regulation of antigen processing and presentation (GO:0002577) | 2.83806429 |
| 87 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.83546565 |
| 88 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.83176859 |
| 89 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.82474797 |
| 90 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.82474797 |
| 91 | megakaryocyte development (GO:0035855) | 2.80222144 |
| 92 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.80106585 |
| 93 | regulation of defense response to virus by virus (GO:0050690) | 2.79997897 |
| 94 | DNA unwinding involved in DNA replication (GO:0006268) | 2.79878452 |
| 95 | regulation of interleukin-4 production (GO:0032673) | 2.79783490 |
| 96 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 2.78876425 |
| 97 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 2.78876425 |
| 98 | positive regulation of T cell differentiation (GO:0045582) | 2.78236971 |
| 99 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 2.76973181 |
| 100 | regulation of B cell activation (GO:0050864) | 2.76372663 |
| 101 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.76314899 |
| 102 | response to host immune response (GO:0052572) | 2.76314899 |
| 103 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.73911418 |
| 104 | regulation of T cell tolerance induction (GO:0002664) | 2.68155207 |
| 105 | negative regulation of phagocytosis (GO:0050765) | 2.63953045 |
| 106 | positive regulation of interleukin-2 production (GO:0032743) | 2.61943070 |
| 107 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.61860119 |
| 108 | negative regulation of T cell receptor signaling pathway (GO:0050860) | 2.60506765 |
| 109 | positive regulation of intracellular steroid hormone receptor signaling pathway (GO:0033145) | 2.60408205 |
| 110 | leukocyte homeostasis (GO:0001776) | 2.60131285 |
| 111 | natural killer cell differentiation (GO:0001779) | 2.57039370 |
| 112 | translational elongation (GO:0006414) | 2.56112070 |
| 113 | positive regulation of lamellipodium assembly (GO:0010592) | 2.55990518 |
| 114 | lymph node development (GO:0048535) | 2.54019248 |
| 115 | myeloid dendritic cell activation (GO:0001773) | 2.53545065 |
| 116 | T cell activation (GO:0042110) | 2.51796841 |
| 117 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 2.51589486 |
| 118 | definitive hemopoiesis (GO:0060216) | 2.50722786 |
| 119 | cellular response to interleukin-4 (GO:0071353) | 2.49435128 |
| 120 | tolerance induction (GO:0002507) | 2.48092484 |
| 121 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.47314185 |
| 122 | natural killer cell activation (GO:0030101) | 2.45849634 |
| 123 | mature B cell differentiation (GO:0002335) | 2.45346948 |
| 124 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.45277278 |
| 125 | alpha-beta T cell activation (GO:0046631) | 2.44928282 |
| 126 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.44713404 |
| 127 | regulation of response to interferon-gamma (GO:0060330) | 2.42692108 |
| 128 | cellular protein complex disassembly (GO:0043624) | 2.41962328 |
| 129 | ribosomal small subunit biogenesis (GO:0042274) | 2.41594954 |
| 130 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.41397233 |
| 131 | positive regulation of isotype switching (GO:0045830) | 2.40849459 |
| 132 | negative regulation of RNA splicing (GO:0033119) | 2.40590719 |
| 133 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.40447966 |
| 134 | regulation of isotype switching (GO:0045191) | 2.40280208 |
| 135 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.39095785 |
| 136 | negative regulation of adaptive immune response (GO:0002820) | 2.38512088 |
| 137 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.36489239 |
| 138 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.35768014 |
| 139 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.35610086 |
| 140 | T cell proliferation (GO:0042098) | 2.34536681 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.75700829 |
| 2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.86910154 |
| 3 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.74274410 |
| 4 | MYC_22102868_ChIP-Seq_BL_Human | 3.97242152 |
| 5 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.24602483 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.23258419 |
| 7 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.03937421 |
| 8 | MYB_26560356_Chip-Seq_TH2_Human | 2.80400024 |
| 9 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.80354761 |
| 10 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.75609755 |
| 11 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.74844040 |
| 12 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.64607335 |
| 13 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.54966297 |
| 14 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.52048337 |
| 15 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.49355103 |
| 16 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.49156007 |
| 17 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.45250386 |
| 18 | MAF_26560356_Chip-Seq_TH1_Human | 2.39735873 |
| 19 | CIITA_25753668_ChIP-Seq_RAJI_Human | 2.34781039 |
| 20 | UTX_26944678_Chip-Seq_JUKART_Human | 2.31830353 |
| 21 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.31170690 |
| 22 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.15674424 |
| 23 | MYB_26560356_Chip-Seq_TH1_Human | 2.13770953 |
| 24 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.12325595 |
| 25 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.09665670 |
| 26 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.94895030 |
| 27 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.91564254 |
| 28 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.89165694 |
| 29 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.87613424 |
| 30 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.86860636 |
| 31 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.80667675 |
| 32 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.77906933 |
| 33 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.77491825 |
| 34 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.77101342 |
| 35 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.75041674 |
| 36 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.73168113 |
| 37 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.70097060 |
| 38 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.67521751 |
| 39 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.66018812 |
| 40 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.61575865 |
| 41 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.61134891 |
| 42 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.60526673 |
| 43 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.57628247 |
| 44 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.56936063 |
| 45 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.54136068 |
| 46 | MAF_26560356_Chip-Seq_TH2_Human | 1.54069960 |
| 47 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.53898618 |
| 48 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.53511544 |
| 49 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.49776301 |
| 50 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.49162501 |
| 51 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.47290427 |
| 52 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.47137984 |
| 53 | SPI1_23127762_ChIP-Seq_K562_Human | 1.46780763 |
| 54 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.45481919 |
| 55 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.41064595 |
| 56 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.38815528 |
| 57 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.38728324 |
| 58 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.35827238 |
| 59 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.35747836 |
| 60 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.35221208 |
| 61 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.34900574 |
| 62 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.34710455 |
| 63 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.31776650 |
| 64 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.28669534 |
| 65 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.26084208 |
| 66 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.24702291 |
| 67 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.23468203 |
| 68 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.23250723 |
| 69 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.22833208 |
| 70 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.20368055 |
| 71 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.19191698 |
| 72 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.18616595 |
| 73 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.14778379 |
| 74 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.13626549 |
| 75 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.12699992 |
| 76 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.12435843 |
| 77 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.11778063 |
| 78 | GATA1_19941826_ChIP-Seq_K562_Human | 1.11606291 |
| 79 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.11235412 |
| 80 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.10806507 |
| 81 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.10048596 |
| 82 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.09838576 |
| 83 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.09823617 |
| 84 | GATA1_22025678_ChIP-Seq_K562_Human | 1.08536253 |
| 85 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.08212996 |
| 86 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.06373339 |
| 87 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.05021909 |
| 88 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.04534187 |
| 89 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.04375415 |
| 90 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.04237857 |
| 91 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.03536784 |
| 92 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.01947953 |
| 93 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.00583905 |
| 94 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 0.99883139 |
| 95 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.98095330 |
| 96 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.97295129 |
| 97 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.95706205 |
| 98 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.95571305 |
| 99 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.94005967 |
| 100 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 0.93413498 |
| 101 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.91542135 |
| 102 | P300_27268052_Chip-Seq_Bcells_Human | 0.91324427 |
| 103 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 0.91123769 |
| 104 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 0.90543550 |
| 105 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.89477310 |
| 106 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 0.88988413 |
| 107 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.88704878 |
| 108 | GATA3_26560356_Chip-Seq_TH2_Human | 0.88120106 |
| 109 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.87007852 |
| 110 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.86257162 |
| 111 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 0.85569752 |
| 112 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.84724367 |
| 113 | GATA2_19941826_ChIP-Seq_K562_Human | 0.84343422 |
| 114 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.83733187 |
| 115 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.83336699 |
| 116 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.81928114 |
| 117 | TTF2_22483619_ChIP-Seq_HELA_Human | 0.81491665 |
| 118 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.80555991 |
| 119 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.80333501 |
| 120 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 0.80093218 |
| 121 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.79909623 |
| 122 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.79316862 |
| 123 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.78961334 |
| 124 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.78841202 |
| 125 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.78779512 |
| 126 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.78262139 |
| 127 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 0.77181959 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003763_abnormal_thymus_physiology | 3.94426052 |
| 2 | MP0005671_abnormal_response_to | 3.40628259 |
| 3 | MP0001835_abnormal_antigen_presentation | 3.31893999 |
| 4 | MP0000685_abnormal_immune_system | 3.03656455 |
| 5 | MP0002396_abnormal_hematopoietic_system | 2.96127424 |
| 6 | MP0001800_abnormal_humoral_immune | 2.89690599 |
| 7 | MP0003724_increased_susceptibility_to | 2.89030073 |
| 8 | MP0002398_abnormal_bone_marrow | 2.77583117 |
| 9 | MP0004859_abnormal_synaptic_plasticity | 2.53636642 |
| 10 | MP0000703_abnormal_thymus_morphology | 2.51765136 |
| 11 | MP0002420_abnormal_adaptive_immunity | 2.46599645 |
| 12 | MP0001819_abnormal_immune_cell | 2.42428826 |
| 13 | MP0004808_abnormal_hematopoietic_stem | 2.37384339 |
| 14 | MP0002166_altered_tumor_susceptibility | 2.29895007 |
| 15 | MP0002723_abnormal_immune_serum | 2.29255527 |
| 16 | MP0005387_immune_system_phenotype | 2.27628588 |
| 17 | MP0001790_abnormal_immune_system | 2.27628588 |
| 18 | MP0002452_abnormal_antigen_presenting | 2.26475971 |
| 19 | MP0003880_abnormal_central_pattern | 2.24275009 |
| 20 | MP0000716_abnormal_immune_system | 2.23459010 |
| 21 | MP0005000_abnormal_immune_tolerance | 2.12012474 |
| 22 | MP0002722_abnormal_immune_system | 2.11449666 |
| 23 | MP0000689_abnormal_spleen_morphology | 2.05928740 |
| 24 | MP0003866_abnormal_defecation | 1.90925288 |
| 25 | MP0009785_altered_susceptibility_to | 1.90820159 |
| 26 | MP0002429_abnormal_blood_cell | 1.87238066 |
| 27 | MP0002006_tumorigenesis | 1.84442301 |
| 28 | MP0003787_abnormal_imprinting | 1.81149756 |
| 29 | MP0009333_abnormal_splenocyte_physiolog | 1.78499975 |
| 30 | MP0005174_abnormal_tail_pigmentation | 1.77924337 |
| 31 | MP0005025_abnormal_response_to | 1.76387372 |
| 32 | MP0003635_abnormal_synaptic_transmissio | 1.71731495 |
| 33 | MP0001968_abnormal_touch/_nociception | 1.70976781 |
| 34 | MP0010094_abnormal_chromosome_stability | 1.61675238 |
| 35 | MP0001873_stomach_inflammation | 1.58257864 |
| 36 | MP0002405_respiratory_system_inflammati | 1.57485474 |
| 37 | MP0002735_abnormal_chemical_nociception | 1.54719308 |
| 38 | MP0010155_abnormal_intestine_physiology | 1.49696870 |
| 39 | MP0003303_peritoneal_inflammation | 1.44312255 |
| 40 | MP0001986_abnormal_taste_sensitivity | 1.39920402 |
| 41 | MP0005464_abnormal_platelet_physiology | 1.38865001 |
| 42 | MP0009745_abnormal_behavioral_response | 1.38856994 |
| 43 | MP0000015_abnormal_ear_pigmentation | 1.38703723 |
| 44 | MP0004510_myositis | 1.37474817 |
| 45 | MP0008057_abnormal_DNA_replication | 1.36456836 |
| 46 | MP0002148_abnormal_hypersensitivity_rea | 1.35117163 |
| 47 | MP0002736_abnormal_nociception_after | 1.34957891 |
| 48 | MP0002138_abnormal_hepatobiliary_system | 1.31635968 |
| 49 | MP0008877_abnormal_DNA_methylation | 1.31576948 |
| 50 | MP0008569_lethality_at_weaning | 1.29453812 |
| 51 | MP0004381_abnormal_hair_follicle | 1.27866233 |
| 52 | MP0002095_abnormal_skin_pigmentation | 1.25415387 |
| 53 | MP0005423_abnormal_somatic_nervous | 1.25415036 |
| 54 | MP0002063_abnormal_learning/memory/cond | 1.24882233 |
| 55 | MP0002419_abnormal_innate_immunity | 1.18141589 |
| 56 | MP0002132_abnormal_respiratory_system | 1.15406172 |
| 57 | MP0005397_hematopoietic_system_phenotyp | 1.15118838 |
| 58 | MP0001545_abnormal_hematopoietic_system | 1.15118838 |
| 59 | MP0001533_abnormal_skeleton_physiology | 1.14768354 |
| 60 | MP0003077_abnormal_cell_cycle | 1.13101227 |
| 61 | MP0008469_abnormal_protein_level | 1.12271511 |
| 62 | MP0000490_abnormal_crypts_of | 1.12149556 |
| 63 | MP0003436_decreased_susceptibility_to | 1.07895059 |
| 64 | MP0005075_abnormal_melanosome_morpholog | 1.07685380 |
| 65 | MP0005409_darkened_coat_color | 1.07652712 |
| 66 | MP0002064_seizures | 1.07493288 |
| 67 | MP0002572_abnormal_emotion/affect_behav | 1.06962446 |
| 68 | MP0005645_abnormal_hypothalamus_physiol | 1.04068193 |
| 69 | MP0001845_abnormal_inflammatory_respons | 1.03027314 |
| 70 | MP0002019_abnormal_tumor_incidence | 1.02176235 |
| 71 | MP0003121_genomic_imprinting | 0.97980884 |
| 72 | MP0009764_decreased_sensitivity_to | 0.97311509 |
| 73 | MP0001851_eye_inflammation | 0.97088627 |
| 74 | MP0003300_gastrointestinal_ulcer | 0.96807665 |
| 75 | MP0000465_gastrointestinal_hemorrhage | 0.95542045 |
| 76 | MP0001853_heart_inflammation | 0.95007005 |
| 77 | MP0002009_preneoplasia | 0.94524884 |
| 78 | MP0002933_joint_inflammation | 0.94417966 |
| 79 | MP0006276_abnormal_autonomic_nervous | 0.92575179 |
| 80 | MP0004811_abnormal_neuron_physiology | 0.89677156 |
| 81 | MP0001188_hyperpigmentation | 0.89666949 |
| 82 | MP0009765_abnormal_xenobiotic_induced | 0.89532856 |
| 83 | MP0002163_abnormal_gland_morphology | 0.87835117 |
| 84 | MP0006082_CNS_inflammation | 0.87722488 |
| 85 | MP0005310_abnormal_salivary_gland | 0.87245372 |
| 86 | MP0008995_early_reproductive_senescence | 0.85982519 |
| 87 | MP0008058_abnormal_DNA_repair | 0.85722876 |
| 88 | MP0004947_skin_inflammation | 0.84998817 |
| 89 | MP0003183_abnormal_peptide_metabolism | 0.84866559 |
| 90 | MP0000858_altered_metastatic_potential | 0.84747995 |
| 91 | MP0008961_abnormal_basal_metabolism | 0.84010695 |
| 92 | MP0001663_abnormal_digestive_system | 0.83246765 |
| 93 | MP0009763_increased_sensitivity_to | 0.82634693 |
| 94 | MP0003172_abnormal_lysosome_physiology | 0.82508669 |
| 95 | MP0001970_abnormal_pain_threshold | 0.81593916 |
| 96 | MP0002184_abnormal_innervation | 0.81301825 |
| 97 | MP0002733_abnormal_thermal_nociception | 0.81134489 |
| 98 | MP0002272_abnormal_nervous_system | 0.79829511 |
| 99 | MP0002067_abnormal_sensory_capabilities | 0.79133612 |
| 100 | MP0004957_abnormal_blastocyst_morpholog | 0.78830629 |
| 101 | MP0009278_abnormal_bone_marrow | 0.78667573 |
| 102 | MP0001348_abnormal_lacrimal_gland | 0.77329022 |
| 103 | MP0009379_abnormal_foot_pigmentation | 0.77301536 |
| 104 | MP0003111_abnormal_nucleus_morphology | 0.76153320 |
| 105 | MP0008007_abnormal_cellular_replicative | 0.75132071 |
| 106 | MP0003879_abnormal_hair_cell | 0.73799232 |
| 107 | MP0009046_muscle_twitch | 0.71599613 |
| 108 | MP0003656_abnormal_erythrocyte_physiolo | 0.70488145 |
| 109 | MP0001905_abnormal_dopamine_level | 0.68784756 |
| 110 | MP0001501_abnormal_sleep_pattern | 0.68758757 |
| 111 | MP0002822_catalepsy | 0.68188446 |
| 112 | MP0000569_abnormal_digit_pigmentation | 0.67598149 |
| 113 | MP0002083_premature_death | 0.67508109 |
| 114 | MP0003693_abnormal_embryo_hatching | 0.67172415 |
| 115 | MP0002557_abnormal_social/conspecific_i | 0.66153769 |
| 116 | MP0005084_abnormal_gallbladder_morpholo | 0.65791460 |
| 117 | MP0008874_decreased_physiological_sensi | 0.64134538 |
| 118 | MP0003122_maternal_imprinting | 0.62332605 |
| 119 | MP0000350_abnormal_cell_proliferation | 0.62040954 |
| 120 | MP0000313_abnormal_cell_death | 0.58317493 |
| 121 | MP0002998_abnormal_bone_remodeling | 0.57469047 |
| 122 | MP0000372_irregular_coat_pigmentation | 0.55841658 |
| 123 | MP0002928_abnormal_bile_duct | 0.55564088 |
| 124 | MP0002693_abnormal_pancreas_physiology | 0.54183846 |
| 125 | MP0005220_abnormal_exocrine_pancreas | 0.54085496 |
| 126 | MP0005535_abnormal_body_temperature | 0.52251742 |
| 127 | MP0003252_abnormal_bile_duct | 0.51053063 |
| 128 | MP0003786_premature_aging | 0.50486298 |
| 129 | MP0008260_abnormal_autophagy | 0.49227829 |
| 130 | MP0008004_abnormal_stomach_pH | 0.49108742 |
| 131 | MP0003221_abnormal_cardiomyocyte_apopto | 0.47515690 |
| 132 | MP0000249_abnormal_blood_vessel | 0.47482931 |
| 133 | MP0003828_pulmonary_edema | 0.46382760 |
| 134 | MP0000598_abnormal_liver_morphology | 0.42867896 |
| 135 | MP0009642_abnormal_blood_homeostasis | 0.42536564 |
| 136 | MP0003045_fibrosis | 0.42356064 |
| 137 | MP0004130_abnormal_muscle_cell | 0.42062822 |
| 138 | MP0005451_abnormal_body_composition | 0.38351496 |
| 139 | MP0005381_digestive/alimentary_phenotyp | 0.37927056 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Panhypogammaglobulinemia (HP:0003139) | 4.74296372 |
| 2 | T lymphocytopenia (HP:0005403) | 4.71553997 |
| 3 | Abnormality of T cell number (HP:0011839) | 4.42898047 |
| 4 | IgM deficiency (HP:0002850) | 4.21233391 |
| 5 | Eczematoid dermatitis (HP:0000976) | 4.16659660 |
| 6 | Agammaglobulinemia (HP:0004432) | 4.15323905 |
| 7 | B lymphocytopenia (HP:0010976) | 4.14182188 |
| 8 | Abnormality of B cell number (HP:0010975) | 4.14182188 |
| 9 | Recurrent bronchitis (HP:0002837) | 4.09466747 |
| 10 | Recurrent viral infections (HP:0004429) | 3.99055352 |
| 11 | Chronic otitis media (HP:0000389) | 3.75823706 |
| 12 | Abnormality of T cells (HP:0002843) | 3.75299578 |
| 13 | Thyroiditis (HP:0100646) | 3.67264499 |
| 14 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.67158994 |
| 15 | Increased IgE level (HP:0003212) | 3.56336510 |
| 16 | Severe combined immunodeficiency (HP:0004430) | 3.53488561 |
| 17 | IgG deficiency (HP:0004315) | 3.48599781 |
| 18 | Thrombocytosis (HP:0001894) | 3.37778274 |
| 19 | Increased IgM level (HP:0003496) | 3.35066231 |
| 20 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.34133099 |
| 21 | Spontaneous hematomas (HP:0007420) | 3.33362406 |
| 22 | Recurrent fungal infections (HP:0002841) | 3.30504592 |
| 23 | Myositis (HP:0100614) | 3.19744043 |
| 24 | Recurrent cutaneous fungal infections (HP:0011370) | 3.17114674 |
| 25 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.17114674 |
| 26 | Epistaxis (HP:0000421) | 3.12312895 |
| 27 | Combined immunodeficiency (HP:0005387) | 3.06414397 |
| 28 | Meningitis (HP:0001287) | 3.06376720 |
| 29 | Gastrointestinal infarctions (HP:0005244) | 2.92067491 |
| 30 | Lymphopenia (HP:0001888) | 2.89530725 |
| 31 | Optic neuritis (HP:0100653) | 2.89234595 |
| 32 | Retrobulbar optic neuritis (HP:0100654) | 2.89234595 |
| 33 | Orchitis (HP:0100796) | 2.82467862 |
| 34 | Autoimmune thrombocytopenia (HP:0001973) | 2.80640497 |
| 35 | Verrucae (HP:0200043) | 2.80000800 |
| 36 | Papilloma (HP:0012740) | 2.80000800 |
| 37 | Abnormality of the prostate (HP:0008775) | 2.79806009 |
| 38 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.76228105 |
| 39 | Nasal polyposis (HP:0100582) | 2.73484327 |
| 40 | Gastrointestinal inflammation (HP:0004386) | 2.67528879 |
| 41 | Petechiae (HP:0000967) | 2.66748563 |
| 42 | Abnormality of macrophages (HP:0004311) | 2.63609694 |
| 43 | Abnormality of the fingertips (HP:0001211) | 2.63409931 |
| 44 | Volvulus (HP:0002580) | 2.62866828 |
| 45 | Hypergammaglobulinemia (HP:0010702) | 2.62077363 |
| 46 | Inflammation of the large intestine (HP:0002037) | 2.58474498 |
| 47 | Chronic sinusitis (HP:0011109) | 2.56442309 |
| 48 | Pulmonary infiltrates (HP:0002113) | 2.55375614 |
| 49 | Urticaria (HP:0001025) | 2.55002007 |
| 50 | Abnormality of T cell physiology (HP:0011840) | 2.54718882 |
| 51 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 2.54646558 |
| 52 | Papilledema (HP:0001085) | 2.53140809 |
| 53 | Pustule (HP:0200039) | 2.51875903 |
| 54 | Osteomyelitis (HP:0002754) | 2.49830890 |
| 55 | Abnormality of eosinophils (HP:0001879) | 2.47420588 |
| 56 | Amyotrophic lateral sclerosis (HP:0007354) | 2.45957238 |
| 57 | Focal motor seizures (HP:0011153) | 2.41855136 |
| 58 | Gastrointestinal stroma tumor (HP:0100723) | 2.41761564 |
| 59 | Recurrent sinusitis (HP:0011108) | 2.41609330 |
| 60 | Gingival bleeding (HP:0000225) | 2.40405914 |
| 61 | Cellulitis (HP:0100658) | 2.37137275 |
| 62 | Lymphoma (HP:0002665) | 2.33118617 |
| 63 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.32539458 |
| 64 | Abnormal number of erythroid precursors (HP:0012131) | 2.28713719 |
| 65 | Hyperacusis (HP:0010780) | 2.27554342 |
| 66 | Hypochromic anemia (HP:0001931) | 2.27194554 |
| 67 | Abnormality of the nasal mucosa (HP:0000433) | 2.26582263 |
| 68 | Skin rash (HP:0000988) | 2.26011037 |
| 69 | Colitis (HP:0002583) | 2.25824914 |
| 70 | Basal cell carcinoma (HP:0002671) | 2.24606983 |
| 71 | Hemoptysis (HP:0002105) | 2.20459232 |
| 72 | Hypoplasia of the thymus (HP:0000778) | 2.18578062 |
| 73 | Pulmonary embolism (HP:0002204) | 2.17817967 |
| 74 | Eosinophilia (HP:0001880) | 2.16520635 |
| 75 | Encephalitis (HP:0002383) | 2.15285665 |
| 76 | Keratoconjunctivitis sicca (HP:0001097) | 2.15223207 |
| 77 | Recurrent lower respiratory tract infections (HP:0002783) | 2.14537121 |
| 78 | Bronchitis (HP:0012387) | 2.13248741 |
| 79 | Mediastinal lymphadenopathy (HP:0100721) | 2.12967565 |
| 80 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.11701126 |
| 81 | IgA deficiency (HP:0002720) | 2.10998376 |
| 82 | Amaurosis fugax (HP:0100576) | 2.09252619 |
| 83 | Acute lymphatic leukemia (HP:0006721) | 2.08465222 |
| 84 | Visual hallucinations (HP:0002367) | 2.07051347 |
| 85 | Chest pain (HP:0100749) | 2.04372755 |
| 86 | Vasculitis (HP:0002633) | 2.02812054 |
| 87 | Aplastic anemia (HP:0001915) | 2.02790054 |
| 88 | Acute hepatic failure (HP:0006554) | 2.02416238 |
| 89 | Purpura (HP:0000979) | 2.01874853 |
| 90 | Recurrent abscess formation (HP:0002722) | 2.00943931 |
| 91 | Joint swelling (HP:0001386) | 2.00566383 |
| 92 | Autoimmune hemolytic anemia (HP:0001890) | 2.00553473 |
| 93 | Keratoconjunctivitis (HP:0001096) | 2.00237743 |
| 94 | Abnormality of the pleura (HP:0002103) | 1.97408530 |
| 95 | Hypochromic microcytic anemia (HP:0004840) | 1.96744974 |
| 96 | Recurrent pneumonia (HP:0006532) | 1.95757341 |
| 97 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.95608648 |
| 98 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.93320973 |
| 99 | Microcytic anemia (HP:0001935) | 1.93135068 |
| 100 | Viral hepatitis (HP:0006562) | 1.92908091 |
| 101 | Abnormality of male internal genitalia (HP:0000022) | 1.91571679 |
| 102 | Abnormal hair whorl (HP:0010721) | 1.91062545 |
| 103 | Obstructive lung disease (HP:0006536) | 1.89092507 |
| 104 | Chronic obstructive pulmonary disease (HP:0006510) | 1.89092507 |
| 105 | Atonic seizures (HP:0010819) | 1.88471794 |
| 106 | Muscle fiber atrophy (HP:0100295) | 1.85432930 |
| 107 | Chronic diarrhea (HP:0002028) | 1.85341239 |
| 108 | Leukocytosis (HP:0001974) | 1.85317251 |
| 109 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 1.84891034 |
| 110 | Granulocytopenia (HP:0001913) | 1.84718043 |
| 111 | Recurrent skin infections (HP:0001581) | 1.84420039 |
| 112 | Impaired smooth pursuit (HP:0007772) | 1.83680161 |
| 113 | Broad palm (HP:0001169) | 1.78864410 |
| 114 | Spinal canal stenosis (HP:0003416) | 1.78727064 |
| 115 | Stomatitis (HP:0010280) | 1.73479438 |
| 116 | Abnormality of binocular vision (HP:0011514) | 1.72837341 |
| 117 | Diplopia (HP:0000651) | 1.72837341 |
| 118 | Focal seizures (HP:0007359) | 1.72604981 |
| 119 | Prolonged bleeding time (HP:0003010) | 1.72171603 |
| 120 | Inappropriate behavior (HP:0000719) | 1.71662076 |
| 121 | Hypoproteinemia (HP:0003075) | 1.71101516 |
| 122 | Type 2 muscle fiber atrophy (HP:0003554) | 1.70837834 |
| 123 | Recurrent bacterial skin infections (HP:0005406) | 1.70311605 |
| 124 | Progressive inability to walk (HP:0002505) | 1.69272006 |
| 125 | Pointed chin (HP:0000307) | 1.69060440 |
| 126 | Febrile seizures (HP:0002373) | 1.68599115 |
| 127 | Cutis marmorata (HP:0000965) | 1.66641760 |
| 128 | Sacral dimple (HP:0000960) | 1.66521814 |
| 129 | Truncal ataxia (HP:0002078) | 1.64828200 |
| 130 | Increased nuchal translucency (HP:0010880) | 1.63916349 |
| 131 | Acute myeloid leukemia (HP:0004808) | 1.63582494 |
| 132 | Colon cancer (HP:0003003) | 1.62123425 |
| 133 | Reticulocytopenia (HP:0001896) | 1.61348244 |
| 134 | Optic nerve coloboma (HP:0000588) | 1.60814784 |
| 135 | Recurrent otitis media (HP:0000403) | 1.60522150 |
| 136 | Fatigue (HP:0012378) | 1.60145680 |
| 137 | Sepsis (HP:0100806) | 1.59027620 |
| 138 | Arterial thrombosis (HP:0004420) | 1.58970319 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 4.97811166 |
| 2 | TXK | 3.79421710 |
| 3 | TAOK3 | 3.11948461 |
| 4 | MAP3K12 | 2.81724866 |
| 5 | GRK6 | 2.77700825 |
| 6 | EEF2K | 2.77481429 |
| 7 | PRPF4B | 2.53188583 |
| 8 | ZAP70 | 2.40281846 |
| 9 | ERN1 | 2.38465738 |
| 10 | SYK | 2.32538393 |
| 11 | RIPK4 | 2.30658642 |
| 12 | SIK2 | 2.24170090 |
| 13 | JAK3 | 2.11081340 |
| 14 | ITK | 1.99981969 |
| 15 | KIT | 1.97632329 |
| 16 | MAP3K10 | 1.92927560 |
| 17 | CDC7 | 1.76792105 |
| 18 | BTK | 1.74470885 |
| 19 | MAP2K7 | 1.72089749 |
| 20 | FES | 1.67361044 |
| 21 | TEC | 1.57276933 |
| 22 | IRAK4 | 1.52907369 |
| 23 | TSSK6 | 1.49738077 |
| 24 | DAPK1 | 1.48354589 |
| 25 | LCK | 1.43043265 |
| 26 | TNK2 | 1.41377778 |
| 27 | CDK19 | 1.38320270 |
| 28 | CSF1R | 1.37497925 |
| 29 | SIK3 | 1.37354410 |
| 30 | TGFBR1 | 1.33440807 |
| 31 | MAP3K4 | 1.30418174 |
| 32 | NLK | 1.30072041 |
| 33 | TNIK | 1.26604291 |
| 34 | STK10 | 1.23609348 |
| 35 | FGFR3 | 1.17948070 |
| 36 | BLK | 1.17183239 |
| 37 | PKN2 | 1.15164143 |
| 38 | MINK1 | 1.15060008 |
| 39 | FLT3 | 1.14314357 |
| 40 | MARK1 | 1.13520658 |
| 41 | NTRK3 | 1.05483019 |
| 42 | HCK | 1.03933112 |
| 43 | IKBKE | 1.03744243 |
| 44 | TYK2 | 1.00077093 |
| 45 | CCNB1 | 0.98109481 |
| 46 | BMPR2 | 0.97140353 |
| 47 | MATK | 0.96692044 |
| 48 | CLK1 | 0.95386606 |
| 49 | JAK2 | 0.95197724 |
| 50 | NTRK2 | 0.93102774 |
| 51 | TBK1 | 0.92368747 |
| 52 | JAK1 | 0.91173866 |
| 53 | LYN | 0.90601669 |
| 54 | LRRK2 | 0.89496401 |
| 55 | CDK12 | 0.88836135 |
| 56 | ALK | 0.88656549 |
| 57 | MAP3K11 | 0.88314010 |
| 58 | MAPK11 | 0.83551936 |
| 59 | MAP3K13 | 0.83227472 |
| 60 | PRKCH | 0.80565423 |
| 61 | PRKCQ | 0.79261249 |
| 62 | CAMKK2 | 0.78626996 |
| 63 | MAP3K7 | 0.71765195 |
| 64 | BCKDK | 0.71253560 |
| 65 | MAPK13 | 0.69642364 |
| 66 | PIK3CG | 0.69277303 |
| 67 | FGFR4 | 0.66280676 |
| 68 | BRD4 | 0.66007318 |
| 69 | HIPK2 | 0.65231898 |
| 70 | PASK | 0.65132909 |
| 71 | ACVR1B | 0.65045621 |
| 72 | MARK2 | 0.60432570 |
| 73 | MAPK7 | 0.58889807 |
| 74 | TAOK1 | 0.58299197 |
| 75 | PDK1 | 0.57879522 |
| 76 | MAP2K2 | 0.57008121 |
| 77 | MAP3K9 | 0.56915366 |
| 78 | VRK1 | 0.56753969 |
| 79 | SCYL2 | 0.55033024 |
| 80 | MAP2K4 | 0.54226021 |
| 81 | CDK4 | 0.50881330 |
| 82 | RAF1 | 0.49850622 |
| 83 | RET | 0.49469181 |
| 84 | MAPK4 | 0.49266018 |
| 85 | MAP2K6 | 0.49093483 |
| 86 | MAP3K1 | 0.48491980 |
| 87 | CAMKK1 | 0.47615901 |
| 88 | KDR | 0.47424411 |
| 89 | MST4 | 0.46610710 |
| 90 | ATR | 0.45875540 |
| 91 | CSK | 0.45695818 |
| 92 | UHMK1 | 0.45658261 |
| 93 | TESK2 | 0.45017954 |
| 94 | EPHA3 | 0.45006432 |
| 95 | SMG1 | 0.44797600 |
| 96 | DYRK1B | 0.44163413 |
| 97 | PIM1 | 0.43882685 |
| 98 | MAPK3 | 0.41641520 |
| 99 | FYN | 0.41415441 |
| 100 | MAP3K14 | 0.41340283 |
| 101 | FGR | 0.41082414 |
| 102 | CDK5 | 0.41076080 |
| 103 | PLK2 | 0.41054842 |
| 104 | EPHB1 | 0.40870013 |
| 105 | NME2 | 0.40814276 |
| 106 | NEK2 | 0.40274597 |
| 107 | RPS6KA5 | 0.40181113 |
| 108 | CAMK1 | 0.39501475 |
| 109 | EPHA4 | 0.39282919 |
| 110 | IRAK1 | 0.38495215 |
| 111 | STK24 | 0.38305292 |
| 112 | RPS6KC1 | 0.38020047 |
| 113 | RPS6KL1 | 0.38020047 |
| 114 | CDK6 | 0.37728118 |
| 115 | BRSK1 | 0.37584399 |
| 116 | TAOK2 | 0.37544823 |
| 117 | ADRBK2 | 0.35266872 |
| 118 | TRIB3 | 0.35082474 |
| 119 | MAP2K3 | 0.35071924 |
| 120 | RPS6KB2 | 0.34910838 |
| 121 | MARK3 | 0.34765323 |
| 122 | RPS6KA6 | 0.33902678 |
| 123 | NUAK1 | 0.32919389 |
| 124 | STK11 | 0.32340223 |
| 125 | MAPK12 | 0.32233852 |
| 126 | YES1 | 0.31866673 |
| 127 | DAPK2 | 0.31857430 |
| 128 | MAP3K5 | 0.31673769 |
| 129 | MAP3K6 | 0.31526340 |
| 130 | IKBKB | 0.30280113 |
| 131 | MKNK2 | 0.30238294 |
| 132 | RPS6KA4 | 0.29600279 |
| 133 | ILK | 0.29455523 |
| 134 | RPS6KB1 | 0.29443185 |
| 135 | DYRK1A | 0.24429770 |
| 136 | IRAK2 | 0.23269616 |
| 137 | MAP4K2 | 0.22923504 |
| 138 | CDK9 | 0.21248193 |
| 139 | CDC42BPA | 0.21034848 |
| 140 | PRKCD | 0.20829062 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.87068798 |
| 2 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.36853509 |
| 3 | Asthma_Homo sapiens_hsa05310 | 2.95210372 |
| 4 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.33282177 |
| 5 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.30361264 |
| 6 | DNA replication_Homo sapiens_hsa03030 | 2.08128468 |
| 7 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.97198806 |
| 8 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.82755058 |
| 9 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.65812818 |
| 10 | Mismatch repair_Homo sapiens_hsa03430 | 1.58756955 |
| 11 | Ribosome_Homo sapiens_hsa03010 | 1.56025629 |
| 12 | Long-term potentiation_Homo sapiens_hsa04720 | 1.55679128 |
| 13 | Measles_Homo sapiens_hsa05162 | 1.49832782 |
| 14 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.46625884 |
| 15 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.42541178 |
| 16 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.39820610 |
| 17 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.39377443 |
| 18 | Spliceosome_Homo sapiens_hsa03040 | 1.28101799 |
| 19 | Nicotine addiction_Homo sapiens_hsa05033 | 1.27995181 |
| 20 | Base excision repair_Homo sapiens_hsa03410 | 1.24320425 |
| 21 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.23911303 |
| 22 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.21487389 |
| 23 | Colorectal cancer_Homo sapiens_hsa05210 | 1.20484494 |
| 24 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.17510613 |
| 25 | Leishmaniasis_Homo sapiens_hsa05140 | 1.15674574 |
| 26 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.11879924 |
| 27 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.10126048 |
| 28 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.10122089 |
| 29 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.09137469 |
| 30 | Viral myocarditis_Homo sapiens_hsa05416 | 1.09021121 |
| 31 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.08692351 |
| 32 | Morphine addiction_Homo sapiens_hsa05032 | 1.07374495 |
| 33 | Olfactory transduction_Homo sapiens_hsa04740 | 1.04901302 |
| 34 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.04701246 |
| 35 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.04522256 |
| 36 | Shigellosis_Homo sapiens_hsa05131 | 1.04353674 |
| 37 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.01569465 |
| 38 | Hepatitis B_Homo sapiens_hsa05161 | 1.01368179 |
| 39 | Allograft rejection_Homo sapiens_hsa05330 | 1.00929319 |
| 40 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.00037524 |
| 41 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.99397678 |
| 42 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.99173898 |
| 43 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.98964234 |
| 44 | Circadian entrainment_Homo sapiens_hsa04713 | 0.98590250 |
| 45 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.98106900 |
| 46 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.98003079 |
| 47 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.96616733 |
| 48 | Platelet activation_Homo sapiens_hsa04611 | 0.95680016 |
| 49 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.93012666 |
| 50 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.92559718 |
| 51 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.91277031 |
| 52 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.89532170 |
| 53 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.88933825 |
| 54 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.88403215 |
| 55 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.86847046 |
| 56 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.85371492 |
| 57 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.84901471 |
| 58 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.84609599 |
| 59 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.84043974 |
| 60 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.82850789 |
| 61 | HTLV-I infection_Homo sapiens_hsa05166 | 0.81123314 |
| 62 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.80721463 |
| 63 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.80496158 |
| 64 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.80285781 |
| 65 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.79413679 |
| 66 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.77901170 |
| 67 | Salivary secretion_Homo sapiens_hsa04970 | 0.77592840 |
| 68 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.77238557 |
| 69 | Influenza A_Homo sapiens_hsa05164 | 0.77193234 |
| 70 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.77165788 |
| 71 | Thyroid cancer_Homo sapiens_hsa05216 | 0.76568913 |
| 72 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.75949471 |
| 73 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.75899321 |
| 74 | Glioma_Homo sapiens_hsa05214 | 0.75677241 |
| 75 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.75676840 |
| 76 | Renin secretion_Homo sapiens_hsa04924 | 0.75462238 |
| 77 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.75266364 |
| 78 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.75190711 |
| 79 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.74664896 |
| 80 | Apoptosis_Homo sapiens_hsa04210 | 0.74577885 |
| 81 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.74310128 |
| 82 | Long-term depression_Homo sapiens_hsa04730 | 0.73193800 |
| 83 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.72552930 |
| 84 | Cell cycle_Homo sapiens_hsa04110 | 0.72439260 |
| 85 | RNA degradation_Homo sapiens_hsa03018 | 0.70120069 |
| 86 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.69926532 |
| 87 | Malaria_Homo sapiens_hsa05144 | 0.69743529 |
| 88 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.69476906 |
| 89 | Hepatitis C_Homo sapiens_hsa05160 | 0.68238193 |
| 90 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.67915385 |
| 91 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.67585039 |
| 92 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.67184572 |
| 93 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.64251470 |
| 94 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.64124011 |
| 95 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.63712939 |
| 96 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.63460189 |
| 97 | Salmonella infection_Homo sapiens_hsa05132 | 0.63391500 |
| 98 | Tuberculosis_Homo sapiens_hsa05152 | 0.63301262 |
| 99 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.61942259 |
| 100 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.61506452 |
| 101 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.60620985 |
| 102 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.60354219 |
| 103 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.60228203 |
| 104 | Homologous recombination_Homo sapiens_hsa03440 | 0.60198383 |
| 105 | Taste transduction_Homo sapiens_hsa04742 | 0.60157609 |
| 106 | Endometrial cancer_Homo sapiens_hsa05213 | 0.60123186 |
| 107 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.57115970 |
| 108 | GABAergic synapse_Homo sapiens_hsa04727 | 0.56971536 |
| 109 | Phagosome_Homo sapiens_hsa04145 | 0.56643022 |
| 110 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.55629381 |
| 111 | RNA transport_Homo sapiens_hsa03013 | 0.54622355 |
| 112 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.54377390 |
| 113 | * Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.53568464 |
| 114 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.50844543 |
| 115 | Legionellosis_Homo sapiens_hsa05134 | 0.47198020 |
| 116 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.46439157 |
| 117 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.43584211 |
| 118 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.43312442 |
| 119 | Alcoholism_Homo sapiens_hsa05034 | 0.42528791 |
| 120 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.41592194 |
| 121 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.38853081 |
| 122 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.38332351 |
| 123 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.34526676 |
| 124 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.34430976 |
| 125 | Pertussis_Homo sapiens_hsa05133 | 0.33609592 |
| 126 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.33136592 |
| 127 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.32760823 |
| 128 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.32679714 |
| 129 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.32235169 |
| 130 | Endocytosis_Homo sapiens_hsa04144 | 0.29249564 |
| 131 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.26051796 |
| 132 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.25825583 |
| 133 | Other glycan degradation_Homo sapiens_hsa00511 | 0.25443511 |
| 134 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.25028399 |
| 135 | Prostate cancer_Homo sapiens_hsa05215 | 0.21800577 |
| 136 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.20301218 |

